Abstract

An increased breast cancer risk during adulthood has been linked to estrogen exposure during fetal life. However, the impossibility of removing estrogens from the feto-maternal unit has hindered the testing of estrogen’s direct effect on mammary gland organogenesis. To overcome this limitation, we developed an ex vivo culture method of the mammary gland where the direct action of estrogens can be tested during embryonic days (E)14 to 19. Mouse mammary buds dissected at E14 and cultured for 5 days showed that estrogens directly altered fetal mammary gland development. Exposure to 0.1 pM, 10 pM, and 1 nM 17 β-estradiol (E2) resulted in monotonic inhibition of mammary buds ductal growth. In contrast, Bisphenol-A (BPA) elicited a non-monotonic response. At environmentally relevant doses (1 nM), BPA significantly increased ductal growth, as previously observed in vivo, while 1 μM BPA significantly inhibited ductal growth. Ductal branching followed the same pattern. This effect of BPA was blocked by Fulvestrant, a full estrogen antagonist, while the effect of estradiol was not. This method may be used to study the hormonal regulation of mammary gland development, and to test newly synthesized chemicals that are released into the environment without proper assessment of their hormonal action on critical targets like the mammary gland.

Highlights

  • An increased breast cancer risk during adulthood has been linked to estrogen exposure during fetal life

  • Cultured fetal mammary glands of CD-1 mice develop in estrogen-free conditions and show similar structures as those observed in vivo

  • We first compared the development of the fetal mammary ductal system in hormone-free conditions [10% charcoal dextran-stripped fetal bovine serum (CDFBS)] to that obtained when the mammary glands were cultured in medium containing 10% FBS

Read more

Summary

Introduction

An increased breast cancer risk during adulthood has been linked to estrogen exposure during fetal life. The impossibility of removing estrogens from the feto-maternal unit has hindered the testing of estrogen’s direct effect on mammary gland organogenesis To overcome this limitation, we developed an ex vivo culture method of the mammary gland where the direct action of estrogens can be tested during embryonic days (E)[14] to 19. The presence of AFP hinders the study of direct effects of estrogen on the mouse fetal mammary gland. Notwithstanding, environmental estrogens such as BPA increased the propensity of developing mammary cancer[7,8,9,10,11,12]. This modification enabled us to perform a quantitative analysis of the consequences of exposure to estrogenic compounds based on morphometric parameters

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call